Intragenic and structural variation of SMN2 modifies clinical severity of spinal muscular atrophy


  • SMN2 copy number appears to be the most important predictor of the clinical phenotype in individuals with spinal muscular atrophy.

Why this matters

    Greater understanding of genetic variants that underlie clinical heterogeneity in spinal muscular atrophy is urgently required to improve neonatal screening programs and therapeutic strategies. The observation that gene copies of SMN2 are structurally different both between and within individuals could have important consequences for current counselling and treatment practices.

¿Quiere leer más?

Inicie sesión o regístrese para acceder a todo el contenido de Neurodiem.

¿Ya tiene una cuenta? Inicie sesión

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.